Article Details

FDA Clears Ravulizumab for Neuromyelitis Optica Spectrum Disorder - Medscape

Retrieved on: 2024-03-25 20:42:21

Tags for this article:

Click the tags to see associated articles and topics

FDA Clears Ravulizumab for Neuromyelitis Optica Spectrum Disorder - Medscape. View article details on hiswai:

Excerpt

NMOSD is a rare inflammatory syndrome of the central nervous system and can cause irreversible disability. ... immune system, from attacking healthy ...

Article found on: www.medscape.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo